DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Illumina (NASDAQ: ILMN)

172.26 -5.66 (-3.18%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ILMN $172.26 -3.18%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $179.07
Previous Close $177.92
Daily Range $171.29 - $180.45
52-Week Range $72.77 - $185.00
Market Cap $24.0B
P/E Ratio 117.83
Dividend (Yield) $0.00 (0.0%)
Volume 2,878,285
Average Daily Volume 1,025,173
Current FY EPS $2.29

Sector

Healthcare

Industry

Drugs

Illumina (ILMN) Description

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Website: http://www.illumina.com/

News & Commentary

Why Google Wants to Map Your Body With Its Baseline Study

Google recently announced that it will collect genetic information from thousands of people to “map out” the healthy human body. Here’s what you need to know about the Google Baseline Study.

Integra Poised on Impressive Duraseal Product Line, Solid Q2 - Analyst Blog

Alder Biopharmaceuticals (ALDR) in Focus: Stock Up 5.2% - Tale of the Tape

Notable ETF Inflow Detected - VXF, AAL, LVS, ILMN

Nasdaq 100 Movers: ADBE, WFM

Is Illumina (ILMN) a Buy on Solid Q2, Strategic Road Map? - Analyst Blog

Dendreon (DNDN) in Focus: Stock Up 9.4% - Tale of the Tape

Dendreon (DNDN) in Focus: Stock Up 9.4% - Tale of the Tape

Cytokinetics (CYTK) Looks Strong: Stock Gains 17.2% - Tale of the Tape

Nasdaq 100 Movers: GRMN, LBTYA

Myriad Genetics Posts Encouraging myPath Melanoma Data - Analyst Blog

Why Illumina (ILMN) Stock Is Gaining Today

See More ILMN News...

ILMN's Top Competitors

ILMN $172.26 (-3.18%)
Current stock: ILMN
TMO $123.24 (-0.72%)
Current stock: TMO
$0.00 (0.00%)
Current stock:
QGEN $23.64 (-0.84%)
Current stock: QGEN